Martin Taphoorn

机构：Leiden University Medical Center, Medisch Centrum Haaglanden · ORCID：0000-0001-9949-4722

发表论文 361 篇 · 总被引 47078 次 · h-index 56

代表论文

• Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions (2025 · Neuro-Oncology · 被引 70)
• Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation study (2025 · EClinicalMedicine · 被引 22)
• Flexibility in patient-reported outcome and health-related quality of life measurement: The EORTC Quality of Life Group measurement strategy (2025 · European Journal of Cancer · 被引 19)
• The use of EORTC QLQ-C30 Summary Score in cancer research and its performance as compared with the EORTC QLQ-C30 Global Health/Quality of Life scale: A systematic review and comparative analysis of effect sizes (2025 · European Journal of Cancer · 被引 7)
• Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU) (2026 · Journal of Clinical Oncology · 被引 4)
• Challenges in interpreting individual-level changes in health-related quality of life in patients with glioma using minimally important differences (MIDs) and a 4-point Likert scale (2025 · Quality of Life Research · 被引 3)